In the latest issue:

Real Men Go to Tehran

Adam Shatz

What Trump doesn’t know about Iran

Patrick Cockburn

Kaiser Karl V

Thomas Penn

The Hostile Environment

Catherine Hall

Social Mobilities

Adam Swift

Short Cuts: So much for England

Tariq Ali

What the jihadis left behind

Nelly Lahoud

Ray Strachey

Francesca Wade

C.J. Sansom

Malcolm Gaskill

At the British Museum: ‘Troy: Myth and Reality’

James Davidson

Poem: ‘The Lion Tree’

Jamie McKendrick


Jenny Turner

Boys in Motion

Nicholas Penny

Jia Tolentino

Lauren Oyler

Diary: What really happened in Yancheng?

Long Ling

Short Cuts: Harry Goes Rogue

Jonathan Parry

Trillion Dollar DiseaseJames Meek

Terms and Conditions

These terms and conditions of use refer to the London Review of Books and the London Review Bookshop website ( — hereafter ‘LRB Website’). These terms and conditions apply to all users of the LRB Website ("you"), including individual subscribers to the print edition of the LRB who wish to take advantage of our free 'subscriber only' access to archived material ("individual users") and users who are authorised to access the LRB Website by subscribing institutions ("institutional users").

Each time you use the LRB Website you signify your acceptance of these terms and conditions. If you do not agree, or are not comfortable with any part of this document, your only remedy is not to use the LRB Website.

  1. By registering for access to the LRB Website and/or entering the LRB Website by whatever route of access, you agree to be bound by the terms and conditions currently prevailing.
  2. The London Review of Books ("LRB") reserves the right to change these terms and conditions at any time and you should check for any alterations regularly. Continued usage of the LRB Website subsequent to a change in the terms and conditions constitutes acceptance of the current terms and conditions.
  3. The terms and conditions of any subscription agreements which educational and other institutions have entered into with the LRB apply in addition to these terms and conditions.
  4. You undertake to indemnify the LRB fully for all losses damages and costs incurred as a result of your breaching these terms and conditions.
  5. The information you supply on registration to the LRB Website shall be accurate and complete. You will notify the LRB promptly of any changes of relevant details by emailing the registrar. You will not assist a non-registered person to gain access to the LRB Website by supplying them with your password. In the event that the LRB considers that you have breached the requirements governing registration, that you are in breach of these terms and conditions or that your or your institution's subscription to the LRB lapses, your registration to the LRB Website will be terminated.
  6. Each individual subscriber to the LRB (whether a person or organisation) is entitled to the registration of one person to use the 'subscriber only' content on the web site. This user is an 'individual user'.
  7. The London Review of Books operates a ‘no questions asked’ cancellation policy in accordance with UK legislation. Please contact us to cancel your subscription and receive a full refund for the cost of all unposted issues.
  8. Use of the 'subscriber only' content on the LRB Website is strictly for the personal use of each individual user who may read the content on the screen, download, store or print single copies for their own personal private non-commercial use only, and is not to be made available to or used by any other person for any purpose.
  9. Each institution which subscribes to the LRB is entitled to grant access to persons to register on and use the 'subscriber only' content on the web site under the terms and conditions of its subscription agreement with the LRB. These users are 'institutional users'.
  10. Each institutional user of the LRB may access and search the LRB database and view its entire contents, and may also reproduce insubstantial extracts from individual articles or other works in the database to which their institution's subscription provides access, including in academic assignments and theses, online and/or in print. All quotations must be credited to the author and the LRB. Institutional users are not permitted to reproduce any entire article or other work, or to make any commercial use of any LRB material (including sale, licensing or publication) without the LRB's prior written permission. Institutions may notify institutional users of any additional or different conditions of use which they have agreed with the LRB.
  11. Users may use any one computer to access the LRB web site 'subscriber only' content at any time, so long as that connection does not allow any other computer, networked or otherwise connected, to access 'subscriber only' content.
  12. The LRB Website and its contents are protected by copyright and other intellectual property rights. You acknowledge that all intellectual property rights including copyright in the LRB Website and its contents belong to or have been licensed to the LRB or are otherwise used by the LRB as permitted by applicable law.
  13. All intellectual property rights in articles, reviews and essays originally published in the print edition of the LRB and subsequently included on the LRB Website belong to or have been licensed to the LRB. This material is made available to you for use as set out in paragraph 8 (if you are an individual user) or paragraph 10 (if you are an institutional user) only. Save for such permitted use, you may not download, store, disseminate, republish, post, reproduce, translate or adapt such material in whole or in part in any form without the prior written permission of the LRB. To obtain such permission and the terms and conditions applying, contact the Rights and Permissions department.
  14. All intellectual property rights in images on the LRB Website are owned by the LRB except where another copyright holder is specifically attributed or credited. Save for such material taken for permitted use set out above, you may not download, store, disseminate, republish, post, reproduce, translate or adapt LRB’s images in whole or in part in any form without the prior written permission of the LRB. To obtain such permission and the terms and conditions applying, contact the Rights and Permissions department. Where another copyright holder is specifically attributed or credited you may not download, store, disseminate, republish, reproduce or translate such images in whole or in part in any form without the prior written permission of the copyright holder. The LRB will not undertake to supply contact details of any attributed or credited copyright holder.
  15. The LRB Website is provided on an 'as is' basis and the LRB gives no warranty that the LRB Website will be accessible by any particular browser, operating system or device.
  16. The LRB makes no express or implied representation and gives no warranty of any kind in relation to any content available on the LRB Website including as to the accuracy or reliability of any information either in its articles, essays and reviews or in the letters printed in its letter page or material supplied by third parties. The LRB excludes to the fullest extent permitted by law all liability of any kind (including liability for any losses, damages or costs) arising from the publication of any materials on the LRB Website or incurred as a consequence of using or relying on such materials.
  17. The LRB excludes to the fullest extent permitted by law all liability of any kind (including liability for any losses, damages or costs) for any legal or other consequences (including infringement of third party rights) of any links made to the LRB Website.
  18. The LRB is not responsible for the content of any material you encounter after leaving the LRB Website site via a link in it or otherwise. The LRB gives no warranty as to the accuracy or reliability of any such material and to the fullest extent permitted by law excludes all liability that may arise in respect of or as a consequence of using or relying on such material.
  19. This site may be used only for lawful purposes and in a manner which does not infringe the rights of, or restrict the use and enjoyment of the site by, any third party. In the event of a chat room, message board, forum and/or news group being set up on the LRB Website, the LRB will not undertake to monitor any material supplied and will give no warranty as to its accuracy, reliability, originality or decency. By posting any material you agree that you are solely responsible for ensuring that it is accurate and not obscene, defamatory, plagiarised or in breach of copyright, confidentiality or any other right of any person, and you undertake to indemnify the LRB against all claims, losses, damages and costs incurred in consequence of your posting of such material. The LRB will reserve the right to remove any such material posted at any time and without notice or explanation. The LRB will reserve the right to disclose the provenance of such material, republish it in any form it deems fit or edit or censor it. The LRB will reserve the right to terminate the registration of any person it considers to abuse access to any chat room, message board, forum or news group provided by the LRB.
  20. Any e-mail services supplied via the LRB Website are subject to these terms and conditions.
  21. You will not knowingly transmit any virus, malware, trojan or other harmful matter to the LRB Website. The LRB gives no warranty that the LRB Website is free from contaminating matter, viruses or other malicious software and to the fullest extent permitted by law disclaims all liability of any kind including liability for any damages, losses or costs resulting from damage to your computer or other property arising from access to the LRB Website, use of it or downloading material from it.
  22. The LRB does not warrant that the use of the LRB Website will be uninterrupted, and disclaims all liability to the fullest extent permitted by law for any damages, losses or costs incurred as a result of access to the LRB Website being interrupted, modified or discontinued.
  23. The LRB Website contains advertisements and promotional links to websites and other resources operated by third parties. While we would never knowingly link to a site which we believed to be trading in bad faith, the LRB makes no express or implied representations or warranties of any kind in respect of any third party websites or resources or their contents, and we take no responsibility for the content, privacy practices, goods or services offered by these websites and resources. The LRB excludes to the fullest extent permitted by law all liability for any damages or losses arising from access to such websites and resources. Any transaction effected with such a third party contacted via the LRB Website are subject to the terms and conditions imposed by the third party involved and the LRB accepts no responsibility or liability resulting from such transactions.
  24. The LRB disclaims liability to the fullest extent permitted by law for any damages, losses or costs incurred for unauthorised access or alterations of transmissions or data by third parties as consequence of visit to the LRB Website.
  25. While 'subscriber only' content on the LRB Website is currently provided free to subscribers to the print edition of the LRB, the LRB reserves the right to impose a charge for access to some or all areas of the LRB Website without notice.
  26. These terms and conditions are governed by and will be interpreted in accordance with English law and any disputes relating to these terms and conditions will be subject to the non-exclusive jurisdiction of the courts of England and Wales.
  27. The various provisions of these terms and conditions are severable and if any provision is held to be invalid or unenforceable by any court of competent jurisdiction then such invalidity or unenforceability shall not affect the remaining provisions.
  28. If these terms and conditions are not accepted in full, use of the LRB Website must be terminated immediately.
The Hungry Gene: The Science of Fat and the Future of Thin 
by Ellen Ruppel Shell.
Atlantic, 294 pp., £17.99, January 2003, 1 84354 141 6
Show More
Show More

A few years ago, Stephen O’Rahilly, a professor of metabolic medicine at Cambridge and consultant of last resort for the dangerously overweight, had two cousins from the Punjab referred to him for treatment. One was an eight-year-old girl who weighed almost 190 pounds and was too heavy to walk. The other was a two-year-old boy. He tipped the scales at 65 pounds. The parents described the children’s ravenous appetites, which no amount of food could sate, how they foraged in rubbish bins for discarded chips, and stole fish fingers from the freezer to chew without waiting for them to thaw. O’Rahilly’s team saw for themselves how the youngsters gorged: the boy would put away 2500 calories at a single meal, and still be up for more.

The scientists discovered that the children had a genetic mutation which meant they lacked a protein called leptin. Leptin had been discovered a few years earlier by scientists in the US working with an insatiable mutant mouse strain called ob. The huge, ever hungry ob mice had also lacked leptin; given it, they rapidly slimmed down. If the obese cousins were given synthetic human leptin, perhaps their desperate desire to eat would fade away, too. It took months to get permission from clinical regulators, but when the children started receiving injections of the substance, the effect was astonishing. They no longer felt that they were starving. The girl got out of her wheelchair and walked again. Was this it? Was leptin the elixir that would make us all lean? It turned out that it was, indeed, able to help a few massively obese individuals around the world – 12, so far, according to Ellen Ruppel Shell – but the rest of the fat world will have to wait longer for its get-thin pills. The truth is, they may never come, but anyone who starts to read this book could be forgiven for thinking we’re almost there.

Shell, who writes, and teaches the writing of, science journalism in the US, has mixed remarkable stories such as that of the Punjabi cousins, with smart reportage and reasonably accessible accounts of the competitive world of obesity research. In the end, however, the disparity between what the book promises and what it delivers is considerable. Shell purports to stand apart from the purveyors of fad diets and failed slimming pills, yet her work involves just as brash a marketing exercise as theirs.

She is selling two ideas. One is that obesity is building into a grand international tragedy. Everyone from the morbidly obese to those with flabby arms and a slight waistband overhang is lumped together in one great mass of ‘casualties’ and ‘victims’. She describes obesity researchers as ‘heroes’. That Frank Shuttlesmith from Des Moines, 48 years old and with generations of comfortable forebears stretching out behind him, is a noble victim of a fearful global epidemic because he’s thick around the middle, doesn’t care to walk and enjoys extra cheese on his burgers, is an attractive proposition.

The other idea she is selling is that society has been unfair to the overweight and the obese; that science tells us people are fat because they are genetically programmed to eat more. Shell presents enough intriguing evidence to suggest that this is partly true. Still, she overdoes it. The opening of the book hints that the overweight are completely at the mercy of an inner eating machine they are powerless to switch off, but that science is about to find the switch. A telling passage which seems to belong more to the inspirational world of self-help and dieting manuals than to a book concerned with scientific data informs us that ‘at the heart of the story are the people whose lives are bound by their struggle with weight. It is their stories – the eminently human ones – that are the common thread, and it is their lives that this book is meant to change.’ Maybe. But I wonder how delighted these people are going to be to reach the end of the book, only to find the author expounding on ways to get people to eat less fast food and walk more. All that hope, and it comes down to fresh fruit and vegetables, and exercise. Again. Damn!

The number of people who are dangerously obese is large and growing, and not just in the rich world. So is the number who have the lesser problem of being technically ‘overweight’. Grouping together those who are in imminent danger of multiple organ failure because they are so heavy with those who are stout is misleading. Being a few pounds overweight may increase the risk of heart disease and other nasties, but everyone has to die of something. The experience which unites all the overweight, from the massively obese to the faintly porky, may be not health problems but a loss of dignity, whether it involves the quest for food, the search for a way to become thin or submitting to the lies of the marketeers who plug both.

In the US, people spend $33 billion a year on weight-loss products. Marketing and research by food and pharmaceutical companies – a distinction which is beginning to blur with the introduction of ‘nutraceuticals’ – is aimed at making us buy and eat more food, and buy and take expensive anti-fat drugs, all at the same time. One genetics researcher interviewed by Shell refers to obesity as ‘the trillion dollar disease’.

Behind the parade of diets and workout regimes there have been more direct interventions. In the postwar West, doctors have tried binding patients’ gullets as Japanese fishermen do cormorants’; inserting and inflating balloons in people’s stomachs; tying cords around their waists; and wiring up their jaws (patients were advised to keep a set of wire-cutters with them at all times in case of emergencies, such as vomiting). In the 1960s and 1970s, a hundred thousand Americans had intestinal bypasses, which meant that food simply slipped through them. Many suffered side effects, including infections and liver failure. Some died.

The current surgical fashion is gastric bypass surgery, a drastic operation in which a surgeon removes a patient’s stomach, uses a powerful stapler to close up most of it, leaving only a two-tablespoon pouch available for food, and puts it back. In 2000, forty thousand Americans had the operation. Last year, it was more than sixty thousand. Every hundredth patient dies on the operating table, and unpleasant side effects kill and bring much suffering to others. It works – on average, bypassees lose 60 per cent of their weight over 18 months – but then it can stop working. US guidelines say that only those whose weight causes severe health problems should be considered for surgery. In practice, this means anyone with a Body Mass Index of 40 or more. BMI is your weight in kilogrammes divided by the square of your height in metres – a BMI of more than 25 is considered overweight, 35 or more is obese. Millions of Americans qualify: in Mississippi, a quarter of the population is obese.

Shell saw the operation performed on a woman who weighs 20 stone and is 5'3" tall. The patient’s daughter and two of her colleagues had already had the operation and shed wheelbarrows of fat between them. The surgeon, Edward Mun, who has operated on people weighing as much as 700 pounds, has to plunge his arm in up to his elbow to fish for the woman’s stomach, a moment Shell recounts in fascinated detail: ‘The flesh ripples thickly, like a crème brûlée . . . the skin bursts open with the force of the fat beneath . . . the smell . . . is savoury, like hamburgers spitting on a grill. The translucent fat layer glistens yellow.’

With juvenile obesity on the rise, surgeons propose carrying out gastric bypasses on 12-year-old children. Mun admits to Shell that the operation is barbaric, but ‘it’s all we’ve got.’ It is not necessarily enough. The patient Shell follows loses a miraculous 125 pounds in the months following the operation. Then she discovers how to eat more by melting biscuits in her mouth before swallowing them, and the weight begins to return. The 90 pounds her daughter lost came back, too. I wonder how long it will be before surgeons begin offering to remove entire stomachs. As some cancer patients discover, it is possible to live without one.

Between the gastric bypass and the difficult discipline of diet and exercise, lies the murky territory of anti-fat medication. Shell is good on the often incestuous relationship between the pharma-food corporations and obesity researchers. She points out that many of the most prominent obesity researchers in the US are consultants to, or receive research grants from, the various industries which help Westerners get fat and promise to help them get thin.

In the 1990s, a combination of two drugs, fenfluramine and phentermine – fen-phen – was shown to have a mild short-term effect in helping overweight people lose a few pounds. The drugs had been approved separately but not in combination by the Food and Drug Administration, and on the back of massive media hype, the weight-loss industry began selling them like popcorn. In 1995, the FDA turned down an application by a subsidiary of American Home Products to market a more powerful form of fenfluramine, Redux. They were concerned by reports that a hundred people in Europe – where Redux was produced – had developed a rare, incurable and fatal respiratory disease after taking it. AHP and their allies lobbied for a second hearing and, despite fresh evidence that the drug was dangerous and not particularly effective, the FDA approved it in 1996. A year and 18 million prescriptions later, it transpired that as many as 30 per cent of the people who took Redux had suffered some damaging side effect. The FDA withdrew it from the market, but not before hundreds of people had become seriously, and in some cases terminally, ill. In 2001, AHP set aside $12 billion to settle lawsuits brought on account of the drug.

Meridia, which has been approved for use in the NHS under the brand name Reductil, has been the subject of a $50 million marketing campaign in the US, aimed at doctors and their weight-conscious middle-aged female patients. It was discovered by accident at laboratories then belonging to Boots in Nottingham, and subsequently bought by BASF. The drug, generically known as sibutramine, was supposed to be an anti-depressant, but patients who took it stayed depressed and lost weight. There are still doubts about its effectiveness and its safety. In some patients, it raises blood pressure, which weight loss is supposed to lower. In March last year, Italian regulators took it off the market after two women died and dozens of other patients reported high blood pressure, accelerated heartbeat, anxiety and gastrointestinal problems.

Shell reveals the ugliness of the weight-pill peddler’s trade. Wyeth-Ayerst, for example, which distributed Redux, paid two distinguished obesity researchers, Albert Stunkard and F. Xavier Pi-Sunyer, to pose as authors of favourable papers they neither wrote nor researched. Another eminent obesity specialist, George Bray, fumes that only 2 per cent of the 36 million Americans with a BMI of more than 30 take obesity drugs – ‘a disappointing failure at the marketing end’.

And yet Shell’s scepticism, even cynicism about the actions and motives of those involved in obesity research sits uncomfortably with her eager portrayal of the progress that scientists are making in understanding the biological basis of fatness. It’s true that this is a difficult time for science writers: it is hard to reconcile the excitement of discovery in the new genetic wonderland with the sordid and premature commercialisation of those discoveries. Shell does not meet the challenge. It sometimes seems as if The Hungry Gene was produced by two different writers: the first is determined to explain how far we have come in understanding the science of obesity, with all the academic rivalries, triumphs and false dawns along the way; the second assembles a saga of commercial greed, regulatory failure and systemic betrayal of the citizen.

The burden of Shell’s argument in the early part of the book seems to be that our traditional understanding of obesity as a failure of individual willpower is being proved wrong in the laboratory: that genes play a more significant role, perhaps the dominant one, in determining who overeats and who does not. She quotes scientists such as O’Rahilly, who are angry at society’s reluctance to acknowledge the part inheritance plays in overeating. ‘I’m sometimes criticised by so-called liberals, who tell me that I shouldn’t be working to validate these nasty people whose disgusting behaviour has made them so sick,’ he says. ‘People who are not victims of these disorders have claimed the moral high ground; they believe themselves to be virtuous. But the truth is, they’re just lucky.’

Genetics-based obesity research has three broad components. There is the race to map the hunger ‘pathway’, the cascade of chemical messages from our metabolism to our brain which add up to the fateful want-food signal, a race consuming hundreds of millions of dollars, immense stretches of human and computer time, and tens of thousands of mutant mice.

There is the study of ethnic groups which seem particularly susceptible to catastrophic weight gain when exposed to the Western lifestyle. Shell visits Kosrae, effectively a US military colony in Micronesia, where almost 85 per cent of those between the ages of 45 and 64 are obese. None of the shops sells fresh fruit or fish and the islanders use imported artificial coconut flavouring instead of the real coconuts, which nobody bothers to collect. They gorge themselves on imported turkey tails and drive everywhere. Some older Kosraeans will no longer drink unsweetened water. Most hospital in-patients are being treated for diet-related diabetes. Nine out of ten surgical operations, many of them amputations, are linked to diabetes.

Scientists believe that, before Westerners arrived, the Kosraeans were exposed to savage famines caused by typhoons, in which up to 90 per cent of the population died. Such extreme events can cause rapid evolutionary change: those who survive famine, so the theory goes, are likely to be those able to store fat most effectively in times of plenty. Notionally, they have a ‘thrifty gene’, or, as one researcher puts it, a ‘greedy gene’: they are able to store up more fat than their fellows in the good years, to live off their corpulence when the going gets hard. But if the plenty never goes away these thrifty/greedy genotypes will continue to stuff themselves in thrall to an impulse over which they have no control.

The third direction of obesity research is into the mysterious, and still disputed, realm of foetal programming; the theory that the food a person is exposed to in the womb affects their propensity to obesity in later life. Evidence for this came in the 1970s, from studies of adults whose mothers had been pregnant during the Nazi-organised famine in the Netherlands in 1944. The children of mothers exposed to famine in the first six months of pregnancy were 80 per cent more likely to be obese when they grew up. It seemed as if a mechanism had been acquired that primed a child for scarcity from birth; when that child was born into a land of plenty, it grew up perilously fat.

All this research points to one broad conclusion that it is hard to argue with: millions of years of evolution, through the extreme swings in food availability which occur in the wild, have bequeathed us a metabolism designed to cope with alternate scarcity and abundance, an abundance, however, which can be harvested only by a great expenditure of energy. In the sedentary, mechanised, fast-food world of the 21st century, there is no such scarcity, and no such expenditure of energy. Beyond that, the conclusions are open to dispute. Far from showing science closing in on a medical solution, as the opening of her book suggests she will, Shell reveals only that every step the scientists take brings new mysteries to light and emphasises how entangled are the natural systems which keep us alive.

The story of the discovery of the leptin gene is instructive. A pharmaceutical company paid millions of dollars for the rights to the patented gene. Yet leptin turned out to be far from the natural fatstopper it was first believed to be. Researchers originally thought it was the message the body transmitted to the brain to indicate that it was sated. The higher the leptin levels, the more sure the individual was that he or she had had enough to eat. As it turns out, the brain watches not for rising leptin levels as a sign of fullness, but for lowering leptin levels as a red alert for starvation – hence the Punjabi cousins’ leptinless gorging. Evolution has laid down multiple systems for protecting us against hunger; it has not given us much to protect against plenty.

The appetite pathway, along which the chemical couriers travel with their ‘I am hungry’ messages, is not a single clear track through the tangled forest of genes and proteins, but a winding, forking route that intersects, in ways our minds may not be capable of grasping, with a myriad other pathways carrying equally vital information. Scientists can dig a pit somewhere along the pathway to stop a hunger courier reaching its destination; but what if the courier is carrying more than one message? The tale of the depressed patients in the sibutramine trial who took a pill to make them feel less sad and ended up still depressed but thinner shows both scientists’ lack of knowledge and the way in which mind and body are entwined. Shell barely nods at the relationship between eating and mood, or questions society’s intolerance towards fat people. That being overweight (as opposed to obese) is a burden is never questioned. Having hinted at a scientific revolution, and reassured the obese that it is not their fault, Shell leaves them in the end with nothing to do but listen to her angry calls for subsidised fresh fruit and vegetables in ‘publicly supported food service venues’.

It is easy for obesity researchers and the socially concerned to be more interested in fat people’s bodies than their souls. For the merely overweight, at least, the worse thing may not be the fatty food they eat or the slimming remedies they turn to, but the swallowing of the lies involved in their promotion. Shell makes an interesting point about very fat people: in order to carry that enormous extra weight around with them, they have much more powerful muscles than less fat people do. It isn’t that inside every fat man there is a thin man trying to get out; every fat man is actually a thin man carrying another thin man with him wherever he goes. The obese are stronger than the non-obese think.

Send Letters To:

The Editor
London Review of Books,
28 Little Russell Street
London, WC1A 2HN

Please include name, address, and a telephone number.


Vol. 25 No. 16 · 21 August 2003

James Meek’s review of The Hungry Gene (LRB, 7 August) reminded me of an unconvincing documentary broadcast earlier this year by Channel 4, proposing that obesity might be caused by a virus. The programme makers tested a dozen or so fat people for antibodies to the virus in question and it was horribly sad to see the responses of those who tested negative: learning that they hadn’t been infected plunged them into guilty despair. Meanwhile, the advertising of SlimFast is apparently being stepped up in an attempt to combat the success of the Atkins diet: Dr Atkins’ New Diet Revolution (1992) is second only to the new Harry Potter in the bestseller lists – never mind that low-carbohydrate, high-fat, high-protein diets have been linked to colorectal cancer, heart disease and kidney damage. Sometimes it’s healthy to be a little overweight.

Jennifer Wilkinson
Lymington, Hampshire

send letters to

The Editor
London Review of Books
28 Little Russell Street
London, WC1A 2HN

Please include name, address and a telephone number

Read anywhere with the London Review of Books app, available now from the App Store for Apple devices, Google Play for Android devices and Amazon for your Kindle Fire.

Sign up to our newsletter

For highlights from the latest issue, our archive and the blog, as well as news, events and exclusive promotions.